Clearstead Advisors’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Clearstead Advisors's GOSS Position: Q2 2026 in Review
Clearstead Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 23,550 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2263.
Clearstead Advisors first reported a position in GOSS in Q1 2020 and has held it in 26 quarters since. The position peaked at $73.4K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Clearstead Advisors held 23,550 shares of Gossamer Bio worth $3.88K as of Q2 2026.
- Clearstead Advisors left its Gossamer Bio share count unchanged in Q2 2026.
- Gossamer Bio made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2263 holding.
- Clearstead Advisors first reported a position in Gossamer Bio in Q1 2020 and has held it in 26 quarters since.
- Clearstead Advisors's Gossamer Bio position peaked at $73.4K in Q4 2025.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.